Filed: 11/4/2025ACC: 0001766574-25-000012
📋 What this filing means
KINNEVIK AB (PUBL) filed this quarterly 13F‑HR report disclosing 1 equity positions with a total reported market value of $65.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
1
Positions
$65.56M
Total AUM (reported)
13.43M
Total Shares
Allocation by class
CL A$65.56M100.0%
Portfolio Concentration
Top 3$65.56M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.43M
Sole
Full voting authority
13.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings1
Rows:
Recursion Pharmaceuticals, Inc.
DFNDShares13.43M
TypeSH
Market value$65.56M
100.00%
Sole
13.43M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc.DFND | CL A | 13.43M | SH | $65.56M 100.00% | 13.43M | 0.00 | 0.00 |